Gilead Sciences, Inc. (GILD) on GreekSoup https://greeksoup.ai/stocks/us/gild/ Every dated entry in the public record on Gilead Sciences, Inc.: results, filings, insider trades and the rest, from the filings, the last 90 days. en Wed, 23 Sep 2026 00:00:00 +0000 Gilead Sciences, Inc.: Dickinson Andrew D (Chief Financial Officer) sold 3,000 shares at $145.29 on 15 September 2026, $435,870https://greeksoup.ai/stocks/us/gild/insiders/us:GILD:insider:2026-09-16:2834cef0e0Wed, 16 Sep 2026 00:00:00 +0000Insider tradeInsider trade. The filing. The page on GreekSoup.

]]> Gilead Sciences, Inc.: Mercier Johanna (Chief Comm & Corp Aff Officer) sold 1,600 shares at $143.69 on 15 September 2026, $229,907https://greeksoup.ai/stocks/us/gild/insiders/us:GILD:insider:2026-09-16:240709a874Wed, 16 Sep 2026 00:00:00 +0000Insider tradeInsider trade. The filing. The page on GreekSoup.

]]> Gilead Sciences, Inc.: Mercier Johanna (Chief Comm & Corp Aff Officer) sold 800 shares at $144.46 on 15 September 2026, $115,566https://greeksoup.ai/stocks/us/gild/insiders/us:GILD:insider:2026-09-16:ad762d5af3Wed, 16 Sep 2026 00:00:00 +0000Insider tradeInsider trade. The filing. The page on GreekSoup.

]]> Gilead Sciences, Inc.: Mercier Johanna (Chief Comm & Corp Aff Officer) sold 600 shares at $145.29 on 15 September 2026, $87,174https://greeksoup.ai/stocks/us/gild/insiders/us:GILD:insider:2026-09-16:0a2699e600Wed, 16 Sep 2026 00:00:00 +0000Insider tradeInsider trade. The filing. The page on GreekSoup.

]]> Gilead Sciences, Inc.: Form 144, JOHANNA MERCIER plans to sell 3,000 shares worth $432,646 around 15 September 2026https://greeksoup.ai/stocks/us/gild/planned-sales/us:GILD:planned-sale:2026-09-15:25ab06125dTue, 15 Sep 2026 00:00:00 +0000Form 144Form 144. The filing. The page on GreekSoup.

]]> Gilead Sciences, Inc.: Form 144, ANDREW DICKINSON plans to sell 3,000 shares worth $435,870 around 15 September 2026https://greeksoup.ai/stocks/us/gild/planned-sales/us:GILD:planned-sale:2026-09-15:11ed61262aTue, 15 Sep 2026 00:00:00 +0000Form 144Form 144. The filing. The page on GreekSoup.

]]> Gilead Sciences, Inc.: O'Day Daniel Patrick (Chairman & CEO) sold 1,600 shares at $147.51 on 1 September 2026, $236,014https://greeksoup.ai/stocks/us/gild/insiders/us:GILD:insider:2026-09-02:f82a6601e2Wed, 02 Sep 2026 00:00:00 +0000Insider tradeInsider trade. The filing. The page on GreekSoup.

]]> Gilead Sciences, Inc.: O'Day Daniel Patrick (Chairman & CEO) sold 7,992 shares at $148.36 on 1 September 2026, $1.2 millionhttps://greeksoup.ai/stocks/us/gild/insiders/us:GILD:insider:2026-09-02:61c6d06053Wed, 02 Sep 2026 00:00:00 +0000Insider tradeInsider trade. The filing. The page on GreekSoup.

]]> Gilead Sciences, Inc.: O'Day Daniel Patrick (Chairman & CEO) sold 5,408 shares at $149.38 on 1 September 2026, $807,856https://greeksoup.ai/stocks/us/gild/insiders/us:GILD:insider:2026-09-02:4e2b2ff034Wed, 02 Sep 2026 00:00:00 +0000Insider tradeInsider trade. The filing. The page on GreekSoup.

]]> Gilead Sciences, Inc.: short interest 23,007,029 shares at the 31 August 2026 settlement, 4.23 days to coverhttps://greeksoup.ai/stocks/us/gild/short-interest/us:GILD:short-interest:2026-08-31:356d3efaf7Mon, 31 Aug 2026 00:00:00 +0000Short interestShort interest. The filing. The page on GreekSoup.

]]> Gilead Sciences, Inc.: Welters Anthony (Director) sold 3,118 shares at $148.31 on 26 August 2026, $462,432https://greeksoup.ai/stocks/us/gild/insiders/us:GILD:insider:2026-08-27:5f9e9ea516Thu, 27 Aug 2026 00:00:00 +0000Insider tradeInsider trade. The filing. The page on GreekSoup.

]]> Gilead Sciences, Inc.: Welters Anthony (Director) sold 4,600 shares at $148.82 on 26 August 2026, $684,590https://greeksoup.ai/stocks/us/gild/insiders/us:GILD:insider:2026-08-27:ce696c7848Thu, 27 Aug 2026 00:00:00 +0000Insider tradeInsider trade. The filing. The page on GreekSoup.

]]> Gilead Sciences, Inc.: Welters Anthony (Director) sold 3,402 shares at $148.24 on 26 August 2026, $504,296https://greeksoup.ai/stocks/us/gild/insiders/us:GILD:insider:2026-08-27:64d6786578Thu, 27 Aug 2026 00:00:00 +0000Insider tradeInsider trade. The filing. The page on GreekSoup.

]]> Gilead Sciences, Inc.: Welters Anthony (Director) sold 6,880 shares at $148.82 on 26 August 2026, $1.0 millionhttps://greeksoup.ai/stocks/us/gild/insiders/us:GILD:insider:2026-08-27:32d6f49fd7Thu, 27 Aug 2026 00:00:00 +0000Insider tradeInsider trade. The filing. The page on GreekSoup.

]]> Gilead Sciences, Inc.: Form 144, ANTHONY WELTERS plans to sell 18,000 shares worth $2.7 million around 26 August 2026https://greeksoup.ai/stocks/us/gild/planned-sales/us:GILD:planned-sale:2026-08-26:405aeea9e3Wed, 26 Aug 2026 00:00:00 +0000Form 144Form 144. The filing. The page on GreekSoup.

]]> Gilead Sciences, Inc.: Bluestone Jeffrey (Director) sold 1,165 shares at $143.75 on 20 August 2026, $167,474https://greeksoup.ai/stocks/us/gild/insiders/us:GILD:insider:2026-08-21:de0bdaa002Fri, 21 Aug 2026 00:00:00 +0000Insider tradeInsider trade. The filing. The page on GreekSoup.

]]> Gilead Sciences, Inc.: Bluestone Jeffrey (Director) sold 1,816 shares at $144.92 on 20 August 2026, $263,183https://greeksoup.ai/stocks/us/gild/insiders/us:GILD:insider:2026-08-21:9eacb435a0Fri, 21 Aug 2026 00:00:00 +0000Insider tradeInsider trade. The filing. The page on GreekSoup.

]]> Gilead Sciences, Inc.: Bluestone Jeffrey (Director) sold 1,658 shares at $145.73 on 20 August 2026, $241,618https://greeksoup.ai/stocks/us/gild/insiders/us:GILD:insider:2026-08-21:222ffcff9bFri, 21 Aug 2026 00:00:00 +0000Insider tradeInsider trade. The filing. The page on GreekSoup.

]]> Gilead Sciences, Inc.: Bluestone Jeffrey (Director) sold 26 shares at $146.36 on 20 August 2026, $3,805https://greeksoup.ai/stocks/us/gild/insiders/us:GILD:insider:2026-08-21:d13dcf3f52Fri, 21 Aug 2026 00:00:00 +0000Insider tradeInsider trade. The filing. The page on GreekSoup.

]]> Gilead Sciences, Inc.: Bluestone Jeffrey (Director) sold 335 shares at $146.26 on 20 August 2026, $48,997https://greeksoup.ai/stocks/us/gild/insiders/us:GILD:insider:2026-08-21:1c08ecc370Fri, 21 Aug 2026 00:00:00 +0000Insider tradeInsider trade. The filing. The page on GreekSoup.

]]> Gilead Sciences, Inc.: Form 144, JEFFREY BLUESTONE plans to sell 5,000 shares worth $738,000 around 20 August 2026https://greeksoup.ai/stocks/us/gild/planned-sales/us:GILD:planned-sale:2026-08-20:fefdd3e469Thu, 20 Aug 2026 00:00:00 +0000Form 144Form 144. The filing. The page on GreekSoup.

]]> Gilead Sciences, Inc.: Dickinson Andrew D (Chief Financial Officer) sold 3,000 shares at $138.36 on 17 August 2026, $415,080https://greeksoup.ai/stocks/us/gild/insiders/us:GILD:insider:2026-08-18:bcabf3adb0Tue, 18 Aug 2026 00:00:00 +0000Insider tradeInsider trade. The filing. The page on GreekSoup.

]]> Gilead Sciences, Inc.: Mercier Johanna (Chief Comm & Corp Aff Officer) sold 16,530 shares at $137.37 on 17 August 2026, $2.3 millionhttps://greeksoup.ai/stocks/us/gild/insiders/us:GILD:insider:2026-08-18:b25007b6ecTue, 18 Aug 2026 00:00:00 +0000Insider tradeInsider trade. The filing. The page on GreekSoup.

]]> Gilead Sciences, Inc.: Mercier Johanna (Chief Comm & Corp Aff Officer) sold 11,470 shares at $138.04 on 17 August 2026, $1.6 millionhttps://greeksoup.ai/stocks/us/gild/insiders/us:GILD:insider:2026-08-18:ae2586fa09Tue, 18 Aug 2026 00:00:00 +0000Insider tradeInsider trade. The filing. The page on GreekSoup.

]]> Gilead Sciences, Inc.: Form 144, ANDREW DICKINSON plans to sell 3,000 shares worth $415,080 around 17 August 2026https://greeksoup.ai/stocks/us/gild/planned-sales/us:GILD:planned-sale:2026-08-17:d93d30ebc2Mon, 17 Aug 2026 00:00:00 +0000Form 144Form 144. The filing. The page on GreekSoup.

]]> Gilead Sciences, Inc.: Form 144, JOHANNA MERCIER plans to sell 28,000 shares worth $3.9 million around 17 August 2026https://greeksoup.ai/stocks/us/gild/planned-sales/us:GILD:planned-sale:2026-08-17:7ddbc23aceMon, 17 Aug 2026 00:00:00 +0000Form 144Form 144. The filing. The page on GreekSoup.

]]> Gilead Sciences, Inc.: short interest 23,183,970 shares at the 14 August 2026 settlement, 3.24 days to coverhttps://greeksoup.ai/stocks/us/gild/short-interest/us:GILD:short-interest:2026-08-14:75cbdf5bb4Fri, 14 Aug 2026 00:00:00 +0000Short interestShort interest. The filing. The page on GreekSoup.

]]> Gilead Sciences, Inc. Q2 FY2026 results: revenue $7.8 billion, net income -$10.5 billionhttps://greeksoup.ai/stocks/us/gild/results/fy2026-q2/us:GILD:result:2026-08-06:f5d718b3aeThu, 06 Aug 2026 00:00:00 +0000ResultsResults. The filing. The page on GreekSoup.

]]> Gilead Sciences, Inc. filed S-3ASR: s-3asrhttps://greeksoup.ai/stocks/us/gild/filings/us:GILD:filing:2026-08-06:8f527bca82Thu, 06 Aug 2026 00:00:00 +0000SEC filingSEC filing. The filing. The page on GreekSoup.

]]> Gilead Sciences, Inc. filed 10-Q: form 10-qhttps://greeksoup.ai/stocks/us/gild/filings/us:GILD:filing:2026-08-06:272e94d0ecThu, 06 Aug 2026 00:00:00 +0000SEC filingSEC filing. The filing. The page on GreekSoup.

]]> Gilead Sciences, Inc. filed 8-K: results of operationshttps://greeksoup.ai/stocks/us/gild/filings/us:GILD:filing:2026-08-04:15a71c12f8Tue, 04 Aug 2026 00:00:00 +0000SEC filingSEC filing. The filing. The page on GreekSoup.

]]> Gilead Sciences, Inc.: O'Day Daniel Patrick (Chairman & CEO) sold 6,700 shares at $129.66 on 3 August 2026, $868,711https://greeksoup.ai/stocks/us/gild/insiders/us:GILD:insider:2026-08-04:f69117b29bTue, 04 Aug 2026 00:00:00 +0000Insider tradeInsider trade. The filing. The page on GreekSoup.

]]> Gilead Sciences, Inc.: O'Day Daniel Patrick (Chairman & CEO) sold 7,700 shares at $130.80 on 3 August 2026, $1.0 millionhttps://greeksoup.ai/stocks/us/gild/insiders/us:GILD:insider:2026-08-04:b0cf8776f9Tue, 04 Aug 2026 00:00:00 +0000Insider tradeInsider trade. The filing. The page on GreekSoup.

]]> Gilead Sciences, Inc.: O'Day Daniel Patrick (Chairman & CEO) sold 600 shares at $131.34 on 3 August 2026, $78,806https://greeksoup.ai/stocks/us/gild/insiders/us:GILD:insider:2026-08-04:8c47056a52Tue, 04 Aug 2026 00:00:00 +0000Insider tradeInsider trade. The filing. The page on GreekSoup.

]]> Gilead Sciences, Inc.: Form 144, DANIEL O'DAY plans to sell 55,000 shares worth $7.2 million around 3 August 2026https://greeksoup.ai/stocks/us/gild/planned-sales/us:GILD:planned-sale:2026-08-03:06b184805eMon, 03 Aug 2026 00:00:00 +0000Form 144Form 144. The filing. The page on GreekSoup.

]]> Gilead Sciences, Inc.: short interest 24,385,621 shares at the 31 July 2026 settlement, 3.86 days to coverhttps://greeksoup.ai/stocks/us/gild/short-interest/us:GILD:short-interest:2026-07-31:19412d1becFri, 31 Jul 2026 00:00:00 +0000Short interestShort interest. The filing. The page on GreekSoup.

]]> Gilead Sciences, Inc.: Dickinson Andrew D (Chief Financial Officer) sold 3,000 shares at $129.93 on 15 July 2026, $389,777https://greeksoup.ai/stocks/us/gild/insiders/us:GILD:insider:2026-07-16:a33b51f147Thu, 16 Jul 2026 00:00:00 +0000Insider tradeInsider trade. The filing. The page on GreekSoup.

]]> Gilead Sciences, Inc.: Mercier Johanna (Chief Comm & Corp Aff Officer) sold 3,000 shares at $129.92 on 15 July 2026, $389,758https://greeksoup.ai/stocks/us/gild/insiders/us:GILD:insider:2026-07-16:b323c32691Thu, 16 Jul 2026 00:00:00 +0000Insider tradeInsider trade. The filing. The page on GreekSoup.

]]> Gilead Sciences, Inc.: Form 144, JOHANNA MERCIER plans to sell 3,000 shares worth $389,758 around 15 July 2026https://greeksoup.ai/stocks/us/gild/planned-sales/us:GILD:planned-sale:2026-07-15:c59818534bWed, 15 Jul 2026 00:00:00 +0000Form 144Form 144. The filing. The page on GreekSoup.

]]> Gilead Sciences, Inc.: Form 144, ANDREW DICKINSON plans to sell 3,000 shares worth $389,777 around 15 July 2026https://greeksoup.ai/stocks/us/gild/planned-sales/us:GILD:planned-sale:2026-07-15:1b03c60c30Wed, 15 Jul 2026 00:00:00 +0000Form 144Form 144. The filing. The page on GreekSoup.

]]> Gilead Sciences, Inc.: short interest 25,261,911 shares at the 15 July 2026 settlement, 3.67 days to coverhttps://greeksoup.ai/stocks/us/gild/short-interest/us:GILD:short-interest:2026-07-15:e6240d631fWed, 15 Jul 2026 00:00:00 +0000Short interestShort interest. The filing. The page on GreekSoup.

]]> Gilead Sciences, Inc.: O'Day Daniel Patrick (Chairman & CEO) sold 11,900 shares at $126.09 on 1 July 2026, $1.5 millionhttps://greeksoup.ai/stocks/us/gild/insiders/us:GILD:insider:2026-07-02:2c731b747cThu, 02 Jul 2026 00:00:00 +0000Insider tradeInsider trade. The filing. The page on GreekSoup.

]]> Gilead Sciences, Inc.: O'Day Daniel Patrick (Chairman & CEO) sold 3,100 shares at $127.08 on 1 July 2026, $393,932https://greeksoup.ai/stocks/us/gild/insiders/us:GILD:insider:2026-07-02:1295aa6cddThu, 02 Jul 2026 00:00:00 +0000Insider tradeInsider trade. The filing. The page on GreekSoup.

]]> Gilead Sciences, Inc.: short interest 25,484,358 shares at the 30 June 2026 settlement, 2.66 days to coverhttps://greeksoup.ai/stocks/us/gild/short-interest/us:GILD:short-interest:2026-06-30:eaab2b9a24Tue, 30 Jun 2026 00:00:00 +0000Short interestShort interest. The filing. The page on GreekSoup.

]]>